CompletedNCT00405535
Glycine added to usual care for OCD
About this title
Adjunctive Glycine for Obsessive Compulsive Disorder
Read the official source — NCT00405535Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- OrangeburgSee all locations and recruitment
Study information
Study start dateJune 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- Nathan Kline Institute for Psychiatric Research
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00405535
- Official title
Show the full official title
Adjunctive Glycine for Obsessive Compulsive Disorder
Get this study by email
Recruitment & locations
CompletedOrangeburg
Questions about this study
Who is behind this study?
The study sponsor is Nathan Kline Institute for Psychiatric Research, a research institute.
Did this study involve medication?
Yes. The study involved medication, including glycine.
Who was this study for?
Listed age limits: 18 years to 65 years.
